{
    "id": 27457,
    "fullName": "TNFRSF12A positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "TNFRSF12A positive indicates the presence of the TNFRSF12A gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 51330,
        "geneSymbol": "TNFRSF12A",
        "terms": [
            "TNFRSF12A",
            "CD266",
            "FN14",
            "TWEAKR"
        ]
    },
    "variant": "positive",
    "createDate": "01/19/2018",
    "updateDate": "01/19/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12731,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, higher dose RG7212 treatment decreased tumor Tnfrsf12a (Fn14) and Tnfsf12 (TWEAK) expression in patients with TNFRSF12A-positive advanced solid tumors (PMID: 26446946).",
            "molecularProfile": {
                "id": 28908,
                "profileName": "TNFRSF12A positive"
            },
            "therapy": {
                "id": 6609,
                "therapyName": "RG7212",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 10663,
                    "pubMedId": 26446946,
                    "title": "Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26446946"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28908,
            "profileName": "TNFRSF12A positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}